Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Metastatic Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07252479
What this trial is testing

Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations

Who this might be right for
Solid Tumors (Phase 1)RAS Mutation
Adlai Nortye Biopharma Co., Ltd. 118
Early research (Phase 1)Study completedNCT03941262
What this trial is testing

Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy

Who this might be right for
Refractory CancerMetastatic CancerRecurrent Cancer+4 more
NKGen Biotech, Inc. 27
Early research (Phase 1)Study completedNCT00479583
What this trial is testing

Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX

Who this might be right for
Cancer
Bristol-Myers Squibb 25
Testing effectiveness (Phase 2)UnknownNCT05268666
What this trial is testing

Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid Tumor
Jubilant Therapeutics Inc. 126
Testing effectiveness (Phase 2)Ended earlyNCT04659603
What this trial is testing

Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors

Who this might be right for
Breast Cancer MetastaticPancreatic Carcinoma Metastatic
Sanofi 50
Early research (Phase 1)Study completedNCT01295827
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)

Who this might be right for
Cancer, Solid Tumor
Merck Sharp & Dohme LLC 1,260
Early research (Phase 1)Study completedNCT01327313
What this trial is testing

EMD525797 in Solid Tumor Patients in Japan

Who this might be right for
Solid Tumor
Merck KGaA, Darmstadt, Germany 27
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Early research (Phase 1)UnknownNCT05554666
What this trial is testing

ASKG315 in Patients With Advanced Solid Tumors.

Who this might be right for
Advanced Solid Tumors
AskGene Pharma, Inc. 56
Early research (Phase 1)Looking for participantsNCT04221542
What this trial is testing

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Amgen 479
Testing effectiveness (Phase 2)Active Not RecruitingNCT06188702
What this trial is testing

S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP

Who this might be right for
MTAP-deleted Solid Tumors
Servier Bio-Innovation LLC 60
Early research (Phase 1)WithdrawnNCT00017537
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer

Who this might be right for
Breast CancerGastric CancerLung Cancer+2 more
University of Alabama at Birmingham
Early research (Phase 1)Study completedNCT04423029
What this trial is testing

DF6002 Alone and in Combination With Nivolumab

Who this might be right for
Solid Tumors
Dragonfly Therapeutics 170
Testing effectiveness (Phase 2)Active Not RecruitingNCT05438329
What this trial is testing

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
DualityBio Inc. 1,123
Early research (Phase 1)Ended earlyNCT02784795
What this trial is testing

LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerColon Cancer+2 more
Eli Lilly and Company 94
Early research (Phase 1)Study completedNCT00390156
What this trial is testing

Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor
University of California, San Francisco 35
Early research (Phase 1)Study completedNCT00714181
What this trial is testing

Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Abramson Cancer Center at Penn Medicine 38
Early research (Phase 1)Study completedNCT05508100
What this trial is testing

Dose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid Tumors

Who this might be right for
Advanced Solid Tumor
Immune-Onc Therapeutics 38
Early research (Phase 1)Study completedNCT00968981
What this trial is testing

Hedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

Who this might be right for
Solid Cancers
Genentech, Inc. 67
Early research (Phase 1)Study completedNCT00077077
What this trial is testing

DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Daiichi Sankyo
Next Page